Clinical trial
CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue…
NCT00017446 · Herbert Irving Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00017446 |
|---|---|
| Title | CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma |
| Official title | Phase II Evaluation Of CP4071 In Previously Treated Advanced Sarcomas |
| Lead sponsor | Herbert Irving Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | CP4071 |
| Start date | Oct 1, 2000 |
| First posted | Jun 12, 2003 |
| Last update posted | Jan 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: